Lycobetaine Has Therapeutic Efficacy in Lung Squamous Cell Carcinoma by Targeting USP32 to Trigger Ferroptosis
Ubiquitin-specific protease 32 (USP32), a deubiquitylating enzyme that controls the ubiquitin process, is overexpressed in multiple cancers and serves as a promising therapeutic target for cancer therapy. Drugs targeting ferroptosis have exhibited promising anticancer activity. Lycobetaine (LBT), a...
Saved in:
| Main Authors: | Shangping Xing, Hua Chai, Zhenlong Chen, Shuye Deng, Feifei Nong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/47/3/163 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The functional role of USP32 in non-small cell lung cancer
by: Hua CHAI, et al.
Published: (2025-06-01) -
USP9X suppresses ferroptosis in diabetic kidney disease by deubiquitinating Nrf2 in vitro
by: Ningjun Shao, et al.
Published: (2025-12-01) -
USP39 promote post-translational modifiers to stimulate the progress of cancer
by: Yuli Zhou, et al.
Published: (2025-05-01) -
USP8 protects rat-derived H9C2 cardiomyocytes from doxorubicin-triggered ferroptosis and cell death through deubiquitination-mediated stabilization of MDM4
by: Yixi Li, et al.
Published: (2025-08-01) -
USP5 Suppresses Ferroptosis in Bladder Cancer Through Stabilization of GPX4
by: Caiying Liu, et al.
Published: (2025-03-01)